Aromatase inhibitors for infertility treatment in women with polycystic ovary syndrome
Friday, May 5, 2023 (Source: Cochrane News and Events)
Source: Cochrane News and Events - May 5, 2023 Category: Information Technology Authors: Paolo Rosati Source Type: news
How Fibroids, Endometriosis Affect a Woman's Odds for Ovarian Cancer
THURSDAY, May 4, 2023 -- Having uterine fibroids or endometriosis can increase a woman ’s risk of developing ovarian cancer, but a new study finds that a hysterectomy can lower that risk for both Black and white women with fibroids.
“Conditions... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2023 Category: General Medicine Source Type: news
ImmunoGen Stock Jumps 140% After Positive Drug Trial Data
ImmunoGen’s shares soared 136% on Wednesday after the biotech company reported “significant and clinically meaningful” survival results in a phase 3 trial of its Elahere treatment among patients with ovarian cancer. The trial found that the drug reduced the risk of death by 33% among patients with…#immunogen #imgn #annaberkenblit #elahere (Source: Reuters: Health)
Source: Reuters: Health - May 4, 2023 Category: Consumer Health News Source Type: news
Biotech ImmunoGen Stock Jumps 140% After Positive Drug Trial Data
ImmunoGen’s shares soared 136% on Wednesday after the biotech company reported “significant and clinically meaningful” survival results in a phase 3 trial of its Elahere treatment among patients with ovarian cancer.#immunogen (Source: Reuters: Health)
Source: Reuters: Health - May 3, 2023 Category: Consumer Health News Source Type: news
Doctors thought I was morbidly obese from eating too much. It turns out I had ovarian cysts
Jess Cisco, 32, a mental health nurse in Columbus, Ohio, spent a whole year dieting and exercising but did not lose a single one of her 245lbs. It was then that doctors revealed she had ovarian cysts. (Source: the Mail online | Health)
Source: the Mail online | Health - May 1, 2023 Category: Consumer Health News Source Type: news
Menopause: Ensuring a tranquil transition
The average age for menopause in the U.S. is 51. For some women, menopause can be challenging, but a greater understanding of the symptoms and treatments can help smooth this natural transition. Here are answers to common questions women have about menopause: How do I know if what I'm experiencing is menopause? Menopause is defined as the permanent cessation of menstrual periods. It ’s triggered by a natural decline in female hormones released by the ovaries,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 26, 2023 Category: Databases & Libraries Source Type: news
Guidelines for Assessing Cancer Risk May Need Updating Guidelines for Assessing Cancer Risk May Need Updating
A genetic sequencing effort found more carriers of risk genes for hereditary breast and ovarian cancer or Lynch syndrome than would have been found by following existing genetic testing guidelines.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 25, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Doctor shares 9 'vague' symptoms of ovarian cancer that must not be overlooked
Dr Frankie Jackson-Spencer warned symptoms of cancer can be "vague", but here's what to take note of. (Source: Daily Express - Health)
Source: Daily Express - Health - April 25, 2023 Category: Consumer Health News Source Type: news
Serum GDF9 and BMP15 as Markers of Ovarian Function Serum GDF9 and BMP15 as Markers of Ovarian Function
What could we learn about ovarian function and female fertility from these serum concentrations?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 24, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
TVUS-guided transvaginal biopsy safe, effective for pelvic lesions
Transvaginal ultrasound (TVUS)-guided biopsy can safely and effectively biops...Read more on AuntMinnie.comRelated Reading:
Elastography illuminates cervical changes in pregnant women
Combining TVUS, MRI, physical exams improve diagnosing endometriosis
Ovarian cancer surveillance an option for women with BRCA variants
TVUS reliable as first-line test for endometrial cancer staging
Transvaginal ultrasound may not be needed to check IUD position (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 24, 2023 Category: Radiology Source Type: news
Janssen Marks First Approval Worldwide for AKEEGA ® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations
BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) has granted marketing authorisation for AKEEGA® (niraparib and abiraterone acetate [AA]), in the form of a dual action tablet (DAT), given with prednisone or prednisolone, for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline and/or somatic) in whom chemotherapy is not clinically indicated.2Prostate cancer is the most common cancer in men in Europe, and the sixth-highest cause of cancer-related death worldwide.1...
Source: Johnson and Johnson - April 21, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
Many With Cancer Predisposition Diseases Unaware of Genetic Status
(MedPage Today) -- ORLANDO -- Many patients with BRCA mutations that carry a high risk of hereditary breast and ovarian cancer (HBOC) or with Lynch syndrome are not only unaware of their genetic status, but would not qualify for genetic screening... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 19, 2023 Category: Gastroenterology Source Type: news
Patients Needed for New Mesothelioma Clinical Trial
A new investigational drug for mesothelioma can now begin human trials after it was granted fast-track designation by the U.S. Food and Drug Administration last week. The novel treatment, SnyKIR-110, is a T-cell therapy designed to treat patients with mesothelioma, cholangiocarcinoma (bile duct cancer) and ovarian cancer.
“We are thrilled to receive fast-track designation from the FDA,” said Dr. Bryan Kim, co-founder and CEO of Verismo Therapeutics. “This designation is an important milestone in our efforts to bring this potentially life-saving drug to patients who are in need of new treatment option...
Source: Asbestos and Mesothelioma News - April 19, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Mesothelioma Source Type: news
Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Women
(MedPage Today) -- Preventatively performing bilateral salpingo-oophorectomy (BSO) to remove the ovaries and fallopian tubes during a benign hysterectomy should not be recommended for younger women and should be carefully considered otherwise... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 18, 2023 Category: Hematology Source Type: news
Ovarian Cancer: Key Abstracts From SGO 2023 Ovarian Cancer: Key Abstracts From SGO 2023
Key data in ovarian cancer presented at SGO 2023 include a reassessment of niraparib, olaparib as neoadjuvant therapy, and options in platinum-resistant disease, as reported by Dr Shannon Westin.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 18, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news
